58X-31126-03251
2 vaccinations
3 coded responses
11 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 020 / MA
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Survey response — day 7, dose 1MedDRA: Pregnancy — Feeling: GoodFree text: Pregnancy, BMI of 35MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
-
2021-04-14
Dose 2 — Pfizer-BioNTech
- 2021-04-14
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia oral — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Tongue tinglingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Thirst — Feeling: GoodFree text: ThirstyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-23
- 2021-04-28
- 2022-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech |
Free text
Release 6 — day 7, dose 1
Systemic reaction (other): Pregnancy, BMI of 35
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Tongue tingling
Systemic reaction (other): Thirsty
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Paraesthesia oral | ✓ | ✓ | ✓ |
| SRO | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Thirst | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release